TABLE 8-2.
Schedule and Dosing for Travel Vaccines
Vaccine | Schedule | Minimum Age | Dose (mL) | Route | Booster Dose |
---|---|---|---|---|---|
BCG (live attenuated) | 1 dose | Birth | <30 days: 0.3 mL (dilute to half concentration) >30 days: 0.3 mL |
Intradermal preferred but subcutaneous acceptable | None |
Hepatitis A/B, combined (inactivated/recombinant) | 3 doses: 0, 1, and 6 months | 1 year | 0.5 mL | Intramuscular | None |
Meningococcal – A/C/Y/W-135 (polysaccharide) | 1 dose | 3 months (see text) | 0.5 mL | Subcutaneous | <4 years: 2–3 years ≥4 years: 3–5 years |
Meningococcal – A/C/Y/W-135 (conjugated polysaccharide) | 1 dose | 2 years | 0.5 mL | Intramuscular | <7 years: 3 years ≥7 years: 5 years |
Rabies (inactivated cell culture) | 3 doses: 0, 7, 21 or 28 days | Birth | 1.0 mL | Intramuscular | Consider at 2 years if high-risk |
Typhoid, Ty21a (live attenuated) | 4 doses: alternate days | 6 years | 1 capsule | Oral | 5 years |
Typhoid, Vi (capsular polysaccharide) | 1 dose | 2 years | 0.5 mL | Intramuscular | 2 years |
Yellow fever (live attenuated) | 1 dose | 9 months | 0.5 mL | Subcutaneous | 10 years |
Japanese encephalitis (IXIARO) | 2 doses: 0 and 28 days | 17 years | 0.5 mL | Intramuscular | 1 year |
BCG, bacille Calmette-Guérin